October 17, 2014; doi:10.1152/ajplung.00096.2014.-Excess superoxide has been implicated in pulmonary hypertension (PH). We previously found lung overexpression of the antioxidant extracellular superoxide dismutase (EC-SOD) attenuates PH and pulmonary artery (PA) remodeling. Although comprising a small fraction of total SOD activity in most tissues, EC-SOD is abundant in arteries. We hypothesize that the selective loss of vascular EC-SOD promotes hypoxia-induced PH through redox-sensitive signaling pathways. EC-SOD loxp/loxp ϫ Tg cre/SMMHC mice (SMC EC-SOD KO) received tamoxifen to conditionally deplete smooth muscle cell (SMC)-derived EC-SOD. Mice were exposed to hypobaric hypoxia for 35 days, and PH was assessed by right ventricular systolic pressure measurements and right ventricle hypertrophy. Vascular remodeling was evaluated by morphometric analysis and two-photon microscopy for collagen. We examined cGMP content and soluble guanylate cyclase expression and activity in lung, lung phosphodiesterase 5 (PDE5) expression and activity, and expression of endothelial nitric oxide synthase and GTP cyclohydrolase-1 (GTPCH-1), the rate-limiting enzyme in tetrahydrobiopterin synthesis. Knockout of SMC EC-SOD selectively decreased PA EC-SOD without altering total lung EC-SOD. PH and vascular remodeling induced by chronic hypoxia was augmented in SMC EC-SOD KO. Depletion of SMC EC-SOD did not impact content or activity of lung soluble guanylate cyclase or PDE5, yet it blunted the hypoxia-induced increase in cGMP. Although total eNOS was not altered, active eNOS and GTPCH-1 decreased with hypoxia only in SMC EC-SOD KO. We conclude that the localized loss of PA EC-SOD augments chronic hypoxic PH. In addition to oxidative inactivation of NO, deletion of EC-SOD seems to reduce eNOS activity, further compromising pulmonary vascular function. extracellular superoxide dismutase; pulmonary vascular remodeling; endothelial nitric oxide synthase; guanosine 3=,5=-cyclic monophosphate; hypoxia; guanylate cyclase; phosphodiesterase; nitric oxide synthase PULMONARY HYPERTENSION (PH) is a progressive lethal disease affecting children and adults. The currently available therapies for PH have not adequately improved patient outcomes; therefore, a better understanding of the mechanisms underlying the development of PH is necessary to develop effective therapeutic approaches (18,26,29). Oxidative stress and reactive oxygen species (ROS) signaling are now recognized to have a critical role in the pathogenesis of human PH and animal models of PH (2,7,8,15). This area of investigation has important translational implications since antioxidant treatments interrupt multiple pathological signaling pathways, but it is complicated by the observations that low levels of ROS are essential to normal cell signaling, and the reactions of ROS are highly compartmentalized. This makes it necessary to consider the dysregulation of specific ROS and antioxidants involved in the pathological processes as well as the tissue and cellular compartmentalization ...